Accès gratuit
Med Sci (Paris)
Volume 21, Numéro 3, Mars 2005
Page(s) 302 - 308
Section M/S revues
Publié en ligne 15 mars 2005
  1. Reemtsma K, McCracken BH, Schlegel JU, et al. Heterotransplantation of the kidney : two clinical experiences. Science 1964; 143 : 700–2. [Google Scholar]
  2. Bailey LL, Nehlsen-Cannarella SL, Concepcion W, et al. Baboon-to-human cardiac xenotransplantation in a neonate. JAMA 1985; 254 : 3321–9. [Google Scholar]
  3. Groth CG. Deoxyspergualin in allogeneic kidney and xenogeneic islet transplantation : early clinical trials. Ann NY Acad Sci 1993; 685 : 193–5. [Google Scholar]
  4. Fink JS, Schumacher JM, Ellias SL, et al. Porcine xenografts in Parkinson’s disease and Huntington’s disease patients : preliminary results. Cell Transplant 2000; 9 : 273–8. [Google Scholar]
  5. Soin B, Smith KG, Zaidi A, et al. Physiological aspects of pig-to-primate renal xenotransplantation. Kidney Int 2001; 60 : 1592–7. [Google Scholar]
  6. Cozzi E, Bhatti F, Schmoeckel M, et al. Long-term survival of nonhuman primates receiving life-supporting transgenic porcine kidney xenografts. Transplantation 2000; 70 : 15–21. [Google Scholar]
  7. Ramirez P, Chavez R, Majado M, et al. Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days. Transplantation 2000; 70 : 989–98. [Google Scholar]
  8. Starzl TE, Fung J, Tzakis A, et al. Baboon-to-human liver transplantation. Lancet 1993; 341 : 65–71. [Google Scholar]
  9. Daggett CW, Yeatman M, Lodge AJ, et al. Total respiratory support from swine lungs in primate recipients. J Thorac Cardiovasc Surg 1998; 115 : 19–27. [Google Scholar]
  10. Waterworth PD, Dunning J, Tolan M, et al. Life-supporting pig-to-baboon heart xenotransplantation. J Heart Lung Transplant 1998; 17 : 1201–7. [Google Scholar]
  11. Kuwaki K, Knosalla C, Dor FJ, et al. Suppression of natural and elicited antibodies in pig-to-baboon heart transplantation using a human anti-human CD154 mAb-based regimen. Am J Transplant 2004; 4 : 363–72. [Google Scholar]
  12. Kirchhof N, Shibata S, Wijkstrom M, et al. Reversal of diabetes in non-immunosuppressed rhesus macaques by intraportal porcine islet xenografts precedes acute cellular rejection. Xenotransplantation 2004; 11 : 396–407. [Google Scholar]
  13. Kroshus TJ, Bolman RM, 3rd, Dalmasso AP. Selective IgM depletion prolongs organ survival in an ex vivo model of pig-to-human xenotransplantation. Transplantation 1996; 62 : 5–12. [Google Scholar]
  14. Vanhove B, Bach FH. Human xenoreactive natural antibodies. Avidity and targets on porcine endothelial cells. Transplantation 1993; 56 : 1251–3. [Google Scholar]
  15. Platt JL, Vercellotti GM, Lindman BJ, et al. Release of heparan sulfate from endothelial cells. Implications for pathogenesis of hyperacute rejection. J Exp Med 1990; 171 : 1363–8. [Google Scholar]
  16. Xu Y, Lorf T, Sablinski T, et al. Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Gal-alpha1-3Gal-beta1-4betaGlc-X immunoaffinity column. Transplantation 1998; 65 : 172–9. [Google Scholar]
  17. Leventhal JR, Dalmasso AP, Cromwell JW, et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 1993; 55 : 857–66. [Google Scholar]
  18. Candinas D, Lesnikoski BA, Robson SC, et al. Effect of repetitive high-dose treatment with soluble complement receptor type 1 and cobra venom factor on discordant xenograft survival. Transplantation 1996; 62 : 336–42. [Google Scholar]
  19. Laumonier T, Mohacsi PJ, Matozan KM, et al. Endothelial cell protection by dextran sulfate : a novel strategy to prevent acute vascular rejection in xenotransplantation. Am J Transplant 2004; 4 : 181–7. [Google Scholar]
  20. Dalmasso AP, Vercellotti GM, Platt JL, et al. Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor. Potential for prevention of xenograft hyperacute rejection. Transplantation 1991; 52 : 530–3. [Google Scholar]
  21. Cozzi E, White DJ. The generation of transgenic pigs as potential organ donors for humans. Nat Med 1995; 1 : 964–6. [Google Scholar]
  22. Diamond LE, McCurry KR, Martin MJ, et al. Characterization of transgenic pigs expressing functionally active human CD59 on cardiac endothelium. Transplantation 1996; 61 : 1241–9. [Google Scholar]
  23. McCurry KR, Kooyman DL, Alvarado CG, et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med 1995; 1 : 423–7. [Google Scholar]
  24. Loss M, Vangerow B, Schmidtko J, et al. Acute vascular rejection is associated with systemic complement activation in a pig-to-primate kidney xenograft model. Xenotransplantation 2000; 7 : 186–96. [Google Scholar]
  25. Dehoux JP, de la Parra B, Latinne D, et al. Characterization of baboon anti-porcine IgG antibodies during acute vascular rejection of porcine kidney xenograft. Xenotransplantation 2002; 9 : 338–49. [Google Scholar]
  26. Schaapherder AF, Daha MR, te Bulte MT, et al. Antibody-dependent cell-mediated cytotoxicity against porcine endothelium induced by a majority of human sera. Transplantation 1994; 57 : 1376–82. [Google Scholar]
  27. Ashton-Chess J, Roussel J, Bernard P, et al. The effect of immunoglobulin immunoadsorptions on delayed xenograft rejection of human CD55 transgenic pig kidneys in baboons. Xenotransplantation 2003; 10 : 552–61. [Google Scholar]
  28. Cooper DK, Koren E, Oriol R. Genetically engineered pigs. Lancet 1993; 342 : 682–3. [Google Scholar]
  29. Lai L, Kolber-Simonds D, Park KW, et al. Production of α-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002; 295 : 1089–92. [Google Scholar]
  30. Houser SL, Kuwaki K, Knosalla C, et al. Thrombotic microangiopathy and graft arteriopathy in pig hearts following transplantation into baboons. Xenotransplantation 2004; 11 : 416–25. [Google Scholar]
  31. Kuwaki K, Tseng YL, Dor FJ, et al. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors : initial experience. Nat Med 2005; 11 : 29–31. [Google Scholar]
  32. Yamada K, Yazawa K, Shimizu A, et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med 2005; 11 : 32–4. [Google Scholar]
  33. Chen D, Riesbeck K, McVey JH, et al. Human thrombin and FXa mediate porcine endothelial cell activation. Modulation by expression of TFPI-CD4 and hirudin-CD4 fusion proteins. Xenotransplantation 2001; 8 : 258–65. [Google Scholar]
  34. Riesbeck K, Chen D, Kemball-Cook G, et al. Expression of hirudin fusion proteins in mammalian cells : a strategy for prevention of intravascular thrombosis. Circulation 1998; 98 : 2744–52. [Google Scholar]
  35. Sebille F, Guillet M, Brouard S, et al. T-cell-mediated rejection of vascularized xenografts in the absence of induced anti-donor antibody response. Am J Transplant 2001; 1 : 21–8. [Google Scholar]
  36. Murray AG, Khodadoust MM, Pober JS, et al. Porcine aortic endothelial cells activate human T cells : direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28. Immunity 1994; 1 : 57–63. [Google Scholar]
  37. Rollins SA, Kennedy SP, Chodera AJ, et al. Evidence that activation of human T cells by porcine endothelium involves direct recognition of porcine SLA and costimulation by porcine ligands for LFA-1 and CD2. Transplantation 1994; 57 : 1709–16. [Google Scholar]
  38. Bartholomew AM, Powelson J, Sachs DH, et al. Tolerance in a concordant nonhuman primate model. Transplantation 1999; 68 : 1708–16. [Google Scholar]
  39. Kozlowski T, Shimizu A, Lambrigts D, et al. Porcine kidney and heart transplantation in baboons undergoing a tolerance induction regimen and antibody adsorption. Transplantation 1999; 67 : 18–30. [Google Scholar]
  40. Barth RN, Yamamoto S, LaMattina JC, et al. Xenogeneic thymokidney and thymic tissue transplantation in a pig-to-baboon model. I. Evidence for pig-specific T-cell unresponsiveness. Transplantation 2003; 75 : 1615–24. [Google Scholar]
  41. Gollackner B, Mueller NJ, Houser S, et al. Porcine cytomegalovirus and coagulopathy in pig-to-primate xenotransplantation. Transplantation 2003; 75 : 1841–7. [Google Scholar]
  42. Martin U, Winkler ME, Id M, et al. Productive infection of primary human endothelial cells by pig endogenous retrovirus (PERV). Xenotransplantation 2000; 7 : 138–42. [Google Scholar]
  43. Paradis K, Langford G, Long Z, et al. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 study group. Science 1999; 285 : 1236–41. [Google Scholar]
  44. Levy MF, Crippin J, Sutton S, et al. Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/hCD59) porcine livers : clinical results and lack of pig-to-human transmission of the porcine endogenous retrovirus. Transplantation 2000; 69 : 272–80. [Google Scholar]
  45. Elliott RB, Escobar L, Garkavenko O, et al. No evidence of infection with porcine endogenous retrovirus in recipients of encapsulated porcine islet xenografts. Cell Transplant 2000; 9 : 895–901. [Google Scholar]
  46. Rother RP, Squinto SP. The alpha-galactosyl epitope : a sugar coating that makes viruses and cells unpalatable. Cell 1996; 86 : 185–8. [Google Scholar]
  47. Alexandre GP, Gianello P, Latinne D, et al. Plasmapheresis and splenectomy in experimental renal xenotransplantation.In : Hardy MA, ed. Xenograft 25. New York : Excerpta Medica, 1989 : 259–66. [Google Scholar]
  48. Fischel RJ, Matas AJ, Platt JL, et al. Cardiac xenografting in the pig-to-Rhesus monkey model : manipulation of antiendothelial antibody prolongs survival. J Heart Lung Transplant 1992; 11 : 965–74. [Google Scholar]
  49. Ye Y, Neethling FA, Niekrasz M, et al. Evidence that intravenously administered alpha-galactosyl carbohydrates reduce baboon serum cytotoxicity to pig kidney cells (PK15) and transplanted pig hearts. Transplantation 1994; 58 : 330–7. [Google Scholar]
  50. Schmoeckel M, Bhatti FN, Zaidi A, et al. Orthotopic heart transplantation in a transgenic pig-to-primate model. Transplantation 1998; 65 : 1570–7. [Google Scholar]
  51. Bhatti FN, Schmoeckel M, Zaidi A, et al. Three-month survival of HDAFF transgenic pig hearts transplanted into primates. Transplant Proc 1999; 31 : 958. [Google Scholar]
  52. McGregor CGA, Teotia SS, Schirmer JM, et al. Cardiac xenotransplantation : 4-1/2 month survival in the laboratory. Abstracts of the seventh congress of the International xenotransplantation association, Glasgow, 2003. Xenotransplantation 2003; 10 : 479–537. [Google Scholar]
  53. Menoret S, Plat M, Blancho G, et al. Characterization of human CD55 and CD59 transgenic pigs and kidney xenotransplantation in the pig-to-baboon combination. Transplantation 2004; 77 : 1468–71. [Google Scholar]
  54. Yamada K, Yazawa K, Kamono C, et al. An initial report of alpha-Gal deficient pig-to-baboon renal xenotransplantation : evidence for the benefit of cotransplanting vascularised donor thymic tissue. Abstracts of the seventh congress of the International xenotransplantation association, Glasgow, 2003. Xenotransplantation 2003; 10 : 479–537. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.